Lingyun Song

Title: Lingyun Song: Innovator in Medical Biotechnology

Introduction

Lingyun Song is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical biotechnology, particularly through his innovative work on fusion proteins. His research focuses on developing therapeutic solutions for various diseases.

Latest Patents

Lingyun Song holds a patent for an "Anti-IL-17 antibody/TNFR ECD fusion protein and use thereof." This invention relates to a fusion protein that combines an anti-interleukin-17 antibody with a tumor necrosis factor receptor extracellular region. The patent also includes a polynucleotide encoding the fusion protein, a vector comprising the polynucleotide, and a host cell containing the polynucleotide or vector. The fusion protein is intended for the treatment, prevention, and diagnosis of related diseases in individuals. He has 1 patent to his name.

Career Highlights

Throughout his career, Lingyun Song has worked with notable companies in the biotechnology sector. He has been associated with Beijing Beyond Biotechnology Co., Ltd and Hangzhou Polymed Biopharmaceuticals, Inc. His work in these organizations has contributed to advancements in medical treatments and biopharmaceuticals.

Collaborations

Lingyun has collaborated with several professionals in his field, including Pinliang Hu and Jing Zou, who is a woman. These collaborations have fostered innovation and development in his research endeavors.

Conclusion

Lingyun Song's contributions to medical biotechnology through his patent and career achievements highlight his role as an innovator in the field. His work continues to pave the way for advancements in therapeutic solutions.